Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2,813 | 1 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,813 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $2,813 | 1 | Novartis Pharmaceuticals Corporation ($2,813) |
All Payment Transactions
1 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/24/2020 | Novartis Pharmaceuticals Corporation | DOVITINIB LACTATE (Drug) | — | In-kind items and services | $2,813.00 | Research |
| Study: RESEARCH RELATED PUBLICATIONS SUPPORT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | Novartis Pharmaceuticals Corporation | $2,813 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 4,653 | 7,058 | $457,346 | $59,897 |
| 2022 | 6 | 4,757 | 7,101 | $442,801 | $49,632 |
| 2021 | 10 | 5,077 | 7,648 | $89,439 | $60,721 |
| 2020 | 7 | 4,539 | 6,894 | $84,658 | $47,968 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 1,030 | 2,057 | $63,601 | $17,013 | 26.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 1,026 | 1,099 | $86,497 | $12,182 | 14.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 1,196 | 1,243 | $159,638 | $10,653 | 6.7% |
| 81050 | Urine volume measurement | Office | 2023 | 1,207 | 2,426 | $72,516 | $8,639 | 11.9% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 159 | 171 | $59,222 | $8,234 | 13.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 48 | $13,296 | $2,717 | 20.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 14 | $2,576 | $459.96 | 17.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 1,105 | 1,131 | $85,894 | $12,619 | 14.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 1,180 | 1,213 | $125,965 | $10,090 | 8.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 191 | 197 | $80,033 | $9,756 | 12.2% |
| 81050 | Urine volume measurement | Office | 2022 | 1,191 | 2,385 | $69,089 | $8,538 | 12.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 1,074 | 2,132 | $70,296 | $6,244 | 8.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 43 | $11,524 | $2,386 | 20.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 1,189 | 1,235 | $22,238 | $13,510 | 60.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 1,224 | 1,273 | $15,557 | $10,468 | 67.3% |
| 51702 | Insertion of indwelling bladder catheter, simple | Office | 2021 | 196 | 204 | $14,211 | $10,365 | 72.9% |
| 81050 | Urine volume measurement | Office | 2021 | 1,251 | 2,528 | $10,493 | $9,159 | 87.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 1,129 | 2,278 | $11,271 | $6,663 | 59.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 34 | $7,429 | $4,559 | 61.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 54 | $4,344 | $3,070 | 70.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 15 | $2,093 | $1,569 | 75.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 13 | $1,278 | $903.07 | 70.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 14 | $523.46 | $455.40 | 87.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 1,048 | 1,093 | $21,919 | $11,663 | 53.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 1,099 | 1,148 | $15,793 | $9,229 | 58.4% |
About Dr. Timothy Larson, M.D
Dr. Timothy Larson, M.D is a Nephrology healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093792269.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Larson, M.D has received a total of $2,813 in payments from pharmaceutical and medical device companies, with $2,813 received in 2020. These payments were reported across 1 transactions from 1 company. The most common payment nature is "" ($2,813).
As a Medicare-enrolled provider, Larson has provided services to 19,026 Medicare beneficiaries, totaling 28,701 services with total Medicare billing of $218,219. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology, Nephrology
- Location Rochester, MN
- Active Since 12/28/2005
- Last Updated 08/18/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1093792269
Products in Payments
- DOVITINIB LACTATE (Drug) $2,813
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Rochester
David Bushinsky, Md, MD
Nephrology — Payments: $172,916
Neera Dahl, Md, MD
Nephrology — Payments: $116,887
Daniel Gray, Md, MD
Nephrology — Payments: $113,994
Fernando Fervenza, M.d, M.D
Nephrology — Payments: $87,112
Robert Mayo, M.d, M.D
Nephrology — Payments: $64,976
Leslie Wong, Md, MD
Nephrology — Payments: $64,754